Muhammad Aron Pase. Tirzepatide: Dual GIP GLP-1 Receptor Agonists, from Molecular to Clinical Practice for Treating Type-2 Diabetes and Obesity. InaJEMD 2024, 1 (2), 96-110. https://doi.org/10.66266/inajemd.v1i2.23.